CinCor Pharma Inc (CINC)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: CINC Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2023-02-27	2022-11-28	S Sale	HEALY JAMES Non-Executive Director Major owner	6,000 -100.0% 14.32 85,920 USD	6,000 -100.0%	14.32	85,920 USD
2022-08-17	2022-08-15	B Purchase	5AM Partners VI, LLC Major owner	487,333 +inf% 30.00 14,619,990 USD	487,333 +inf%	30.00	14,619,990 USD
2022-08-17	2022-08-15	B Purchase	5AM Partners VI, LLC Major owner	112,667 +2.9% 30.00 3,380,010 USD	112,667 +2.9%	30.00	3,380,010 USD
2022-08-17	2022-08-15	B Purchase	Sofinnova Partners SAS Major owner	133,333 +3.3% 30.00 3,999,990 USD	133,333 +3.3%	30.00	3,999,990 USD
2022-08-15	2022-08-11	B Purchase	GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Major owner	83,000 +2.0% 30.00 2,490,000 USD	83,000 +2.0%	30.00	2,490,000 USD
2022-08-15	2022-08-11	B Purchase	Sofinnova Venture Partners X, L.P. Major owner	500,000 +9.0% 30.00 15,000,000 USD	500,000 +9.0%	30.00	15,000,000 USD
2022-08-15	2022-08-11	B Purchase	GENERAL ATLANTIC, L.P. Major owner	83,000 +2.0% 30.00 2,490,000 USD	83,000 +2.0%	30.00	2,490,000 USD
2022-08-15	2022-08-11	B Purchase	HEALY JAMES Non-Executive Director Major owner	6,000 +inf% 30.00 180,000 USD	6,000 +inf%	30.00	180,000 USD
2022-08-15	2022-08-11	B Purchase	HEALY JAMES Non-Executive Director Major owner	500,000 +9.0% 30.00 15,000,000 USD	500,000 +9.0%	30.00	15,000,000 USD
2023-02-27	2022-06-10	S Sale	Freeman Mason Chief Medical Officer Officer	6 -0.2% 15.21 91 USD	6 -0.2%	15.21	91 USD
2022-01-13	2022-01-11	B Purchase	Coelho Mary Theresa EVP CFO & Chief BD Officer Officer	100 +inf% 16.00 1,600 USD	100 +inf%	16.00	1,600 USD
2022-01-13	2022-01-11	B Purchase	Sofinnova Venture Partners X, L.P. Major owner	325,000 +6.2% 16.00 5,200,000 USD	325,000 +6.2%	16.00	5,200,000 USD
2022-01-13	2022-01-11	B Purchase	HEALY JAMES Non-Executive Director Major owner	325,000 +6.2% 16.00 5,200,000 USD	325,000 +6.2%	16.00	5,200,000 USD
2022-01-13	2022-01-11	B Purchase	Sofinnova Partners SAS Major owner	220,000 +5.7% 16.00 3,520,000 USD	220,000 +5.7%	16.00	3,520,000 USD
2022-01-13	2022-01-11	B Purchase	5AM Partners VI, LLC Major owner	312,500 +170.0% 16.00 5,000,000 USD	312,500 +170.0%	16.00	5,000,000 USD
2022-01-13	2022-01-11	B Purchase	5AM Partners VI, LLC Major owner	157,500 +4.3% 16.00 2,520,000 USD	157,500 +4.3%	16.00	2,520,000 USD
2022-01-13	2022-01-11	B Purchase	GENERAL ATLANTIC GENPAR (BERMUDA), L.P. Major owner	1,700,000 +70.1% 16.00 27,200,000 USD	1,700,000 +70.1%	16.00	27,200,000 USD
2022-01-13	2022-01-11	B Purchase	de Garidel Marc Chief Executive Officer Executive Director	12,500 +inf% 16.00 200,000 USD	12,500 +inf%	16.00	200,000 USD
2022-01-13	2022-01-11	B Purchase	Pearce Catherine Chief Operating Officer Officer	1,500 +inf% 16.00 24,000 USD	1,500 +inf%	16.00	24,000 USD
2022-01-13	2022-01-11	B Purchase	Pearce Catherine Chief Operating Officer Officer	750 +0.6% 16.00 12,000 USD	750 +0.6%	16.00	12,000 USD
2022-01-13	2022-01-11	B Purchase	Freeman Mason EVP Clinical Development Officer	100 +inf% 16.00 1,600 USD	100 +inf%	16.00	1,600 USD
2022-01-13	2022-01-11	B Purchase	Freeman Mason EVP Clinical Development Officer	2,500 +inf% 16.00 40,000 USD	2,500 +inf%	16.00	40,000 USD
2022-01-13	2022-01-11	B Purchase	GENERAL ATLANTIC, L.P. Major owner	1,700,000 +70.1% 16.00 27,200,000 USD	1,700,000 +70.1%	16.00	27,200,000 USD